NCT04576156 2025-12-04A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor TreatmentGeron CorporationPhase 3 Active not recruiting327 enrolled
NCT05481151 2025-08-13A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PVPharmaEssentiaPhase 3 Active not recruiting111 enrolled